When small-cell lung cancer (SCLC) has spread to distant parts of the body, it’s classified as extensive-stage, which applies ...

UK MHRA approves Accord Healthcare’s anti-PD-1 monoclonal antibody, serplulimab to treat aggressive form of SCLC: United Kingdom Monday, June 23, 2025, 09:00 Hrs [IST] The Medic ...

As with all products, we will keep its safety under close review The Medicines and Healthcare products Regulatory Agency ...

A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year.

Interdisciplinary Genitourinary Cancer Forum featured a metastatic urothelial carcinoma session and a presentation by Dr.

Chemotherapy is a common treatment following a breast cancer diagnosis. It may involve insertion of a port-a-catheter, or “port.” Here are five things to know about ports.

Symbiq raises the bar for infusion pump technology with an innovative and user-centric approach. With its unique combination of nurse-friendly features, auto-default to safety software, and ...